Junwei Shi

14.7k total citations · 4 hit papers
105 papers, 7.3k citations indexed

About

Junwei Shi is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Junwei Shi has authored 105 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 21 papers in Hematology and 19 papers in Genetics. Recurrent topics in Junwei Shi's work include Protein Degradation and Inhibitors (22 papers), Hemoglobinopathies and Related Disorders (19 papers) and RNA modifications and cancer (16 papers). Junwei Shi is often cited by papers focused on Protein Degradation and Inhibitors (22 papers), Hemoglobinopathies and Related Disorders (19 papers) and RNA modifications and cancer (16 papers). Junwei Shi collaborates with scholars based in United States, China and Austria. Junwei Shi's co-authors include Christopher R. Vakoc, Eric Wang, Joseph P. Milazzo, Johannes Zuber, Scott W. Lowe, Meredith J. Taylor, Amy Rappaport, Justin B. Kinney, Jun Qi and Scott C. Kogan and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Junwei Shi

97 papers receiving 7.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

2011 1.4k citations Junwei Shi et al. profile →
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control

2017 815 citations Junwei Shi et al. profile →
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition

2014 664 citations Junwei Shi et al. Molecular Cell profile →
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains

2015 500 citations Junwei Shi et al. Nature Biotechnology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Junwei Shi	6.2k	1.5k	1.3k	808	513	105	7.3k
Rolf Marschalek	3.3k 0.5×	2.0k 1.4×	569 0.4×	412 0.5×	395 0.8×	225	5.4k
Roy M. Pollock	5.4k 0.9×	958 0.7×	636 0.5×	368 0.5×	385 0.8×	55	6.4k
Adrian P. Bracken	7.4k 1.2×	392 0.3×	1.1k 0.8×	1.2k 1.4×	553 1.1×	47	8.5k
Mark Rolfe	4.6k 0.7×	471 0.3×	2.5k 1.8×	570 0.7×	407 0.8×	55	6.0k
Robert J. Sims	5.6k 0.9×	731 0.5×	736 0.5×	351 0.4×	311 0.6×	50	6.1k
Daniel E. Bauer	7.3k 1.2×	1.2k 0.8×	890 0.7×	2.0k 2.5×	560 1.1×	108	9.4k
Bruce E. Clurman	7.8k 1.3×	547 0.4×	4.2k 3.1×	1.2k 1.5×	641 1.2×	77	9.6k
Beric R. Henderson	4.1k 0.7×	588 0.4×	753 0.6×	427 0.5×	206 0.4×	90	5.1k
Takeshi Urano	7.7k 1.2×	285 0.2×	1.5k 1.1×	799 1.0×	910 1.8×	198	9.4k
David T. Weaver	6.5k 1.1×	336 0.2×	2.6k 2.0×	1.3k 1.6×	1.4k 2.6×	150	9.0k

Countries citing papers authored by Junwei Shi

Since Specialization

Citations

This map shows the geographic impact of Junwei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junwei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junwei Shi more than expected).

Fields of papers citing papers by Junwei Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junwei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junwei Shi. The network helps show where Junwei Shi may publish in the future.

Co-authorship network of co-authors of Junwei Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Junwei Shi. A scholar is included among the top collaborators of Junwei Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junwei Shi. Junwei Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdulmalik, Osheiza, Belinda Giardine, Cheryl A. Keller, et al.. (2025). Highly discriminative globin gene activation by the noncanonical BAF chromatin remodeling complex. Blood. 147(6). 675–688.

Wertheim, Gerald, Shikha Gaur, Joseph P. Loftus, et al.. (2025). DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition. Leukemia. 39(5). 1078–1089. 1 indexed citations

Alikarami‬, Fatemeh, Simone S. Riedel, Sarah K. Tasian, et al.. (2025). Upfront menin-inhibitor resistance in multiply pretreated leukemias. Experimental Hematology. 153. 105268–105268. 1 indexed citations

Li, Yu, Liping Qin, Junwei Shi, et al.. (2025). High-spatial resolution imaging of electrochemical oxidation of hydrogen peroxide at the Pt particles using scanning ion conductive microscopy. Electrochimica Acta. 530. 146358–146358.

Shi, Junwei, et al.. (2024). Fine modeling of spatial three-dimensional curved steel box girders based on BIM technology. Results in Engineering. 25. 103729–103729.

Shi, Junwei, et al.. (2024). Dynamic response and densification mechanism of dynamic compaction for silt soil through a large scale field test at Daxing Airport. Soil Dynamics and Earthquake Engineering. 190. 109201–109201. 1 indexed citations

Shen, Lin, Caicun Zhou, Yinghua Ji, et al.. (2024). Results of a phase 1/2 study of MHB088C: A novel B7H3 antibody-drug conjugate (ADC) incorporating a potent DNA topoisomerase I inhibitor in recurrent or metastatic solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 3012–3012. 9 indexed citations

Zhao, Jingru, et al.. (2024). Oncogenic transcription factors instruct promoter-enhancer hubs in individual triple negative breast cancer cells. Science Advances. 10(32). eadl4043–eadl4043. 4 indexed citations

Mittal, Monika, Baiyun Wang, Ning Zheng, et al.. (2024). DCAF15 control of cohesin dynamics sustains acute myeloid leukemia. Nature Communications. 15(1). 5604–5604. 6 indexed citations

10.

Huang, Peng, Scott A. Peslak, Cheryl A. Keller, et al.. (2024). let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching. Blood. 143(19). 1980–1991. 10 indexed citations

11.

Berríos, Kiara N., Juan Carlos Serrano, Jared B. Parker, et al.. (2024). Cooperativity between Cas9 and hyperactive AID establishes broad and diversifying mutational footprints in base editors. Nucleic Acids Research. 52(4). 2078–2090. 2 indexed citations

12.

Hsiung, Chris C.‐S., Caroline Wilson, QiLiang Chen, et al.. (2024). Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations. Nature Biotechnology. 43(3). 369–383. 15 indexed citations

13.

Qin, Kunhua, Xianjiang Lan, Peng Huang, et al.. (2023). Molecular basis of polycomb group protein-mediated fetal hemoglobin repression. Blood. 141(22). 2756–2770. 7 indexed citations

14.

Wu, Jennifer E., Sasikanth Manne, Shin Foong Ngiow, et al.. (2023). In vitro modeling of CD8 ⁺ T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40. Science Immunology. 8(86). eade3369–eade3369. 33 indexed citations

15.

Shi, Junwei, et al.. (2023). Electrochemiluminescence imaging of a membrane carcinoembryonic antigen at single tissue sections. The Analyst. 148(11). 2511–2517. 8 indexed citations

16.

Huang, Peng, Scott A. Peslak, Ren Ren, et al.. (2022). HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription. Nature Genetics. 54(9). 1417–1426. 31 indexed citations

17.

Berríos, Kiara N., Niklaus H. Evitt, Diqiu Ren, et al.. (2021). Controllable genome editing with split-engineered base editors. Nature Chemical Biology. 17(12). 1262–1270. 30 indexed citations

18.

Lan, Xianjiang, Ren Ren, Ruopeng Feng, et al.. (2020). ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression. Blood. 136(Supplement 1). 54–54. 2 indexed citations

19.

Lan, Xianjiang, Ren Ren, Ruopeng Feng, et al.. (2020). ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression. Molecular Cell. 81(2). 239–254.e8. 60 indexed citations

20.

Shi, Junwei. (2011). Observation of clinical curative effect on multi-drug resistant pulmonary tuberculosis in elderly patients.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact